Skip to content
Home/Companies/Biotech/Axoltis Pharma
Axoltis Pharma

Axoltis Pharma

Biotech·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Axoltis Pharma?

Axoltis Pharma is currently owned by ANGELOR through Angelor (2014 vintage), since 2024.

Hand-verified · updated 2026-04-21

ANGELOR
Investor
ANGELOR
Angelor · 2014 · VC

Key facts

HQFrance
SectorBiotech
Websitewww.axoltis.com

More from Angelor

Other portfolio companies in the same fund.

Brenus Pharma
Brenus Pharma
Active
BiotechFrance· 2024
Dillico
Dillico
Active
BiotechFrance· 2024
Hawk Cell
Hawk Cell
Active
BiotechFrance· 2024
Pixee Medical
Active
MedTechFrance· 2024
Standing Ovation
Active
BiotechFrance· 2024
Wise Integration
Wise Integration
Active
TMTFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Axoltis Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Axoltis Pharma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Axoltis Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue